{
  "validation_strategy": {
    "tier_1_screening": {
      "description": "High-throughput initial screening",
      "assays": [
        "elispot"
      ],
      "predictions": [
        {
          "peptide": "KIADYNYKL",
          "prediction_confidence": 0.92,
          "combined_immunogenicity": 0.81,
          "evasion_resistance_score": 0.68,
          "validation_priority_score": 0.8150000000000001
        },
        {
          "peptide": "YLQPRTFLL",
          "prediction_confidence": 0.85,
          "combined_immunogenicity": 0.78,
          "evasion_resistance_score": 0.72,
          "validation_priority_score": 0.793
        },
        {
          "peptide": "NEWEPITOPE",
          "prediction_confidence": 0.76,
          "combined_immunogenicity": 0.69,
          "evasion_resistance_score": 0.74,
          "validation_priority_score": 0.743
        }
      ],
      "estimated_cost": 3000,
      "timeline_weeks": 4
    },
    "tier_2_confirmation": {
      "description": "Confirmation of positive hits",
      "assays": [
        "tetramer_staining",
        "flow_cytometry"
      ],
      "predictions": [
        {
          "peptide": "KIADYNYKL",
          "prediction_confidence": 0.92,
          "combined_immunogenicity": 0.81,
          "evasion_resistance_score": 0.68,
          "validation_priority_score": 0.8150000000000001
        },
        {
          "peptide": "YLQPRTFLL",
          "prediction_confidence": 0.85,
          "combined_immunogenicity": 0.78,
          "evasion_resistance_score": 0.72,
          "validation_priority_score": 0.793
        },
        {
          "peptide": "NEWEPITOPE",
          "prediction_confidence": 0.76,
          "combined_immunogenicity": 0.69,
          "evasion_resistance_score": 0.74,
          "validation_priority_score": 0.743
        }
      ],
      "estimated_cost": 5500,
      "timeline_weeks": 6
    },
    "tier_3_functional": {
      "description": "Functional validation of confirmed epitopes",
      "assays": [
        "cytotoxicity_assay"
      ],
      "predictions": [
        {
          "peptide": "KIADYNYKL",
          "prediction_confidence": 0.92,
          "combined_immunogenicity": 0.81,
          "evasion_resistance_score": 0.68,
          "validation_priority_score": 0.8150000000000001
        },
        {
          "peptide": "YLQPRTFLL",
          "prediction_confidence": 0.85,
          "combined_immunogenicity": 0.78,
          "evasion_resistance_score": 0.72,
          "validation_priority_score": 0.793
        },
        {
          "peptide": "NEWEPITOPE",
          "prediction_confidence": 0.76,
          "combined_immunogenicity": 0.69,
          "evasion_resistance_score": 0.74,
          "validation_priority_score": 0.743
        }
      ],
      "estimated_cost": 1000,
      "timeline_weeks": 4
    }
  },
  "disease_specific_additions": {
    "patient_samples": "Use primary leukemia patient PBMCs",
    "controls": "Include healthy donor controls and remission samples",
    "special_assays": [
      "minimal_residual_disease_monitoring"
    ],
    "considerations": "Account for blast cell interference"
  },
  "total_estimated_cost": 9500,
  "total_timeline_weeks": 6,
  "success_criteria": {
    "primary_endpoint": "Positive response in \u226530% of tested epitopes",
    "secondary_endpoints": [
      "Correlation coefficient >0.6 between predictions and experimental results",
      "Identification of at least 3 high-quality epitopes for vaccine development"
    ],
    "statistical_power": 0.8,
    "significance_level": 0.05
  },
  "risk_mitigation": [
    {
      "risk": "Low experimental sensitivity",
      "probability": "medium",
      "impact": "high",
      "mitigation": "Use positive controls and optimize assay conditions"
    },
    {
      "risk": "Patient sample variability",
      "probability": "high",
      "impact": "medium",
      "mitigation": "Use larger sample sizes and stratify by patient characteristics"
    },
    {
      "risk": "Technical assay failures",
      "probability": "low",
      "impact": "high",
      "mitigation": "Include technical replicates and backup assays"
    }
  ],
  "data_analysis_plan": {
    "primary_analysis": "Correlation analysis between predictions and experimental outcomes",
    "secondary_analyses": [
      "ROC curve analysis for prediction performance",
      "Subgroup analysis by patient characteristics",
      "Feature importance analysis"
    ],
    "statistical_methods": [
      "Pearson correlation",
      "Spearman correlation",
      "Mann-Whitney U test"
    ],
    "visualization": [
      "Scatter plots",
      "ROC curves",
      "Heatmaps"
    ],
    "reporting": "Comprehensive validation report with recommendations for model improvement"
  }
}